The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Pharmaceutical Price Controls and Entry Strategies
Abstract
This paper finds that the use of price controls has a statistically and quantitatively important effect on the extent and timing of the launch of new drugs. Firms headquartered in countries that regulate price reach fewer markets than those in countries without price controls. Companies avoid price-controlled markets, and are less likely to introduce products in additional markets after entering a price-controlled country. Launches into low-price European countries are further delayed following legalization of parallel imports. The results suggest that price regulation in one country affects entry into other countries, and may affect the strategies of domestic firms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Teece, D. (1993) · Research Policy · doi:10.1016/0048-7333(93)90063-n · Cited by 7,242
Djankov, S., La Porta, R., Lopez-de-Silanes, F., & Shleifer, A. (2002) · The Quarterly Journal of Economics · doi:10.1162/003355302753399436 · Cited by 3,956
Event History Analysis : Regression for Longitudinal Event Data
Allison, P. D. (1984) · Cited by 1,711
Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry
Acemoglu, D., & Linn, J. (2004) · The Quarterly Journal of Economics · doi:10.1162/0033553041502144 · Cited by 967
Product Choice and Oligopoly Market Structure
Mazzeo, M. J. (2002) · The RAND Journal of Economics · doi:10.2307/3087431 · Cited by 611
Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act
Grabowski, H. G., & Vernon, J. M. (1992) · The Journal of Law and Economics · doi:10.1086/467257 · Cited by 574
Danzon, P. M., Wang, Y. R., & Wang, L. (2005) · Health Economics · doi:10.1002/hec.931 · Cited by 343
Groups, the Media, Agency Waiting Costs, and FDA Drug Approval
Carpenter, D. P. (2002) · American Journal of Political Science · doi:10.2307/3088394 · Cited by 333
Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry
Finkelstein, A. (2004) · The Quarterly Journal of Economics · doi:10.1162/0033553041382166 · Cited by 321
Cross-national price differences for pharmaceuticals: how large, and why?
Danzon, P. M., & Chao, L.-W. (2000) · Journal of Health Economics · doi:10.1016/s0167-6296(99)00039-9 · Cited by 285
Cited by
Cunningham, C., Ederer, F., & Ma, S. (2021) · Journal of Political Economy · doi:10.1086/712506 · Cited by 452
Metadata
- Authors
- Kyle, M. K.
- Venue
- Review of Economics and Statistics
- Publisher
- MIT Press - Journals
- Published
- 2007-02
- Volume
- 89
- Issue
- 1
- Pages
- 88-99
- ISSN
- 0034-6535 (ISSN-L)
- 1530-9142
- OpenAlex
- W2019152670
- Cited by
- 297
- References
- 16
- FWCI
- 42.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmaceutical Price Controls and Entry Strategies. https://app.cochat.ai/papers/10.1162/rest.89.1.88
- The paper
- Kyle, M. K. (2007). Pharmaceutical Price Controls and Entry Strategies. Review of Economics and Statistics. https://doi.org/10.1162/rest.89.1.88
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.